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Abstract: Proteins must fold into their native structure and maintain it during their lifespan to
display the desired activity. To ensure proper folding and stability, and avoid generation of misfolded
conformations that can be potentially cytotoxic, cells synthesize a wide variety of molecular chaperones
that assist folding of other proteins and avoid their aggregation, which unfortunately is unavoidable
under acute stress conditions. A protein machinery in metazoa, composed of representatives of the
Hsp70, Hsp40, and Hsp110 chaperone families, can reactivate protein aggregates. We revised herein
the phosphorylation sites found so far in members of these chaperone families and the functional
consequences associated with some of them. We also discuss how phosphorylation might regulate the
chaperone activity and the interaction of human Hsp70 with its accessory and client proteins. Finally,
we present the information that would be necessary to decrypt the effect that post-translational
modifications, and especially phosphorylation, could have on the biological activity of the Hsp70
system, known as the “chaperone code”.
Keywords: chaperones; post-translational modification; phosphorylation; human disaggregase;
Hsp40; Hsp70; Hsp110
1. Introduction
The amino acid sequence does not dictate the final chemical composition of proteins, as many of
them undergo post-translational modifications (PTMs) to form the mature polypeptides that define the
cellular proteome [1]. PTMs constitute a main route used by cells to expand and diversify the proteomes
way beyond their genomes predict. There are different protein PTMs that include enablers of location,
function, and signaling, and markers of stability and degradation. They occur on amino acid side chains
or at the protein C- or N-termini, and they extend the chemical properties of the 20 standard amino
acids by modifying existing functional groups or introducing new ones (reviewed in [2]). They are
found in both prokaryotes and eukaryotes, although being more abundant, frequent and diverse in the
latter. About 5% of the genes in eukaryotic DNA code enzymes dedicated to carry out the covalent
modification of proteins.
Phosphorylation is the most studied post-translational protein modification, allowing for simple
and reversible regulation of protein function. Around 30% of human proteins are phosphorylated
during their lifetime [3]. Protein phosphorylation can trigger different and biologically important
effects, such as induction of structural changes, protein labeling for cellular translocation and regulation
of protein–protein interactions [3]. The phosphorylation process is governed by a finely-tuned interplay
of kinases and phosphatases, and can be adjusted in a tissue-specific manner [4]. Here we review
PTMs affecting molecular chaperones, a special class of proteins dedicated to promoting and keeping
the correct folding of the cellular proteome and solubilize and reactivate protein aggregates.
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2. Protein Folding and Molecular Chaperones
Proteins are one of the most important and complex components of the cells. The majority of the
biochemical processes occurring within a cell rely on proteins acting as catalyzers of complex chemical
reactions between biomolecules, transporters, cellular structural scaffolds, etc. The biogenesis of a
protein depends on a key process called protein folding by which polypeptide chains acquire a defined
three-dimensional structure, usually known as the native state, which features thermodynamic stability
and biological activity. Proteins fold using funneled energy landscapes in which the conformational
space that the polypeptide has to sample gets restricted towards the native state due to the hydrophobic
chain collapse and the increasing number of native interactions [5–7]. Many studies have shown
that proteins that have been unfolded in vitro can refold spontaneously into their native states
in dilute solutions at low temperatures in the absence of any other component, demonstrating
that the information required to attain the native state is contained in the primary structure of
the polypeptide [8]. However, proteins within cells encounter conditions that are far from the
ideal in vitro situation. First, newly synthesized polypeptides have to cope with a highly crowded
cellular milieu with a protein concentration of 300–400 g·L–1 [9], that modifies folding landscapes
and favors off-pathway intermolecular interactions between hydrophobic segments that lead to
protein aggregation [10,11]. Second, living organisms can also suffer mutations, different types of
environmental stress and aging that hinder folding of polypeptides after ribosomal synthesis and
can induce unfolding or misfolding of existing proteins. Finally, these issues are aggravated by
the structural flexibility that proteins require to function properly [5,12], making them marginally
stable and susceptible to easily unfold exposing aggregation-prone hydrophobic sequences to the
aqueous medium. A hallmark of protein folding failure is the formation of aggregates that cells
accumulate in specific subcellular compartments as a defense mechanism, sequestering potentially
harmful unfolded polypeptides [13–15]. Protein aggregates can also be secreted to the extracellular
medium by a mechanism not fully understood [16,17]. The risk that protein aggregates represent for
cells and living organisms is manifested by their direct relation with human diseases, especially evident
in neurodegenerative pathologies characterized by the appearance of amyloid fibers [18].
To compensate the difficulties menacing correct protein folding in vivo, cells have evolved a
complex system devoted to facilitate proteins in acquiring and maintaining their native conformations.
This protein quality control (PQC) network, also called proteostasis network, comprises molecular
chaperones, the components of proteasomal degradation and the autophagy system [19]. Molecular
chaperones form coordinated networks to promote de novo folding of polypeptides, rescue misfolded
proteins and prevent aggregation of unfolded polypeptides [20]. However, acute and prolonged stress
can overcome the buffering effect of the proteostasis network, resulting in the increase of unfolded
protein concentration, which in turn derives in aggregation. To ensure survivability, the proteostasis
system can resolve cytotoxic protein aggregates by either reactivating their protein components or
directing them to proteolytic recycling [21–23]. Here we focus on the impact that phosphorylation
of members of the Hsp70, Hsp40, and Hsp110 chaperone families might have on their structure and
biological activity.
3. Molecular Chaperones Involved in Protein Folding and Protein Aggregate Reactivation
Hsp70 chaperones participate in a broad range of biological processes, as they prevent protein
aggregation, promote the refolding of misfolded denatured proteins, reactivate protein aggregates and
collaborate with cellular degradation machineries to clear aberrant proteins and protein aggregates.
Thus, Hsp70s protect cells against the detrimental effects of proteotoxic stresses, pathophysiological
conditions and ageing that cause protein homeostasis imbalance (review in [24]). The human genome
contains at least 13 genes codifying Hsp70 proteins, 6 of which are translated as “canonical” Hsp70s in
the cytosol and nucleus (HSPA1A/B, HSPA1L, HSPA2, HSPA6, and HSPA8). HspA8, also termed Hsc70,
and HspA1A, represent the major non-inducible and stress-inducible Hsp70s in the cytosol, respectively,
and have been found to display significant disaggregase activity on amorphous aggregates and amyloid
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fibers in vitro [25–27]. Different isoforms of Hsp70s are distinguished by their ability to interact with
specific Hsp40s and nucleotide exchange factors (NEFs), to recognize specific substrates, to undergo
allosteric regulation, and to adapt to the conditions of particular cellular compartments [28,29].
The domain architecture of Hsp70, recently reviewed in [24], consists of N- and C-terminal domains
connected by a flexible and highly conserved hydrophobic linker (Figure 1A), essential for allosteric
inter-domain communication [30]. The 45 KDa N-terminal domain (NBD) contains a nucleotide
binding site with high affinity for ATP and ADP, and low intrinsic hydrolase activity. The NBD has
an actin-like configuration with two lobes (I and II) that form a deep cleft where the nucleotide is
bound. The C-terminal substrate binding domain (SBD) is able to bind extended polypeptides rich in
aliphatic residues and is subdivided in a β-sandwich subdomain (SBDβ) that holds the binding site,
an α-helical lid subdomain (SBDα) that locks the substrate, and a C-terminal intrinsically disordered
segment. Hsp70 activity requires a sophisticated allosteric coupling between the NBD and SBD: ATP
binding induces the release of the bound peptide, and substrate binding stimulates ATP hydrolysis.
Figure 1. Human chaperones involved in proteostasis and reactivation of protein aggregates.
(A) Schematic representation of the domain organization of the main proteins comprising the human
disaggregase: Hsp70, Hsp110, and Hsp40 (Classes A and B). Proteins and domains are drawn on scale
according to the length of their amino acid sequences. (B) ATPase and conformational cycle of Hsp70
essential to the chaperone activity. Substrates enter the cycle by binding to Hsp40 and then, they are
transferred to the ATP-bound state of Hsp70. Both, the Hsp40 cochaperone and the substrate stimulate
ATP hydrolysis, closing the SBD and trapping the substrate in the ADP-state. Hsp110 interacts with
the NBD of the chaperone and promotes exchange of ADP by ATP, which triggers the dissociation
of the Hsp70-client complex and thus, the release of the substrate. (C) Ribbon representation of
full-length E. coli Hsp70 (DnaK) in complex with the J-domain of DnaJ (PDB ID:5NRO; [31]) using UCSF
Chimera [32]. (D) Structure of the human Hsp70 NBD in complex with Saccharomyces cerevisiae Hsp110
(PDB ID:3D2F) [33]. (E) Entropic pulling model proposed to act during protein aggregate solubilization
by the Hsp70-system. Hsp40 recruits Hsp70 to the aggregate surface, which results in a reduction of its
entropy. Local unfolding of the bound polypeptide might allow the movement of the Hsp70-client
complex away from the aggregate surface, incrementing the degrees of freedom of the molecules.
This would generate a favorable free energy change (∆G < 0) due to the local entropy increase.
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Hsp70s can be considered molecular machines that modulate the conformation of their substrate
proteins by interacting with short hydrophobic segments exposed to the solvent. The conformational
remodeling of the substrates occurs in successive rounds of binding and release, coupled to the
nucleotide-dependent conformational cycle of Hsp70 (Figure 1B). In the ATP conformation, the SBD
is docked onto the NBD, displaying a low affinity for substrates due to their fast association and
dissociation kinetics [34,35]. Hsp40 cochaperones and the substrate synergistically stimulate ATP
hydrolysis, which induces a large structural rearrangement that includes NDB and SBD disengagement
and lid closure on the substrate, thus enhancing the stability of the chaperone-client complex [36].
Nucleotide exchange factors, as human Hsp110 proteins, promote ADP/ATP exchange in Hsp70,
restarting the cycle and releasing the substrate to the medium. Using this mechanism, DnaK, the main
bacterial Hsp70, functions as an unfoldase, allowing a misfolded mutant of luciferase to reach the
native state [37].
Hsp40s, also called J proteins, constitute a less conserved and larger chaperone family, compared
to Hsp70s, with at least 41 representatives in humans [28,38]. All members of the Hsp40 family share a
conserved domain of approximately 70 residues, called J-domain, usually located in the N-terminus,
which is essential to stimulate the ATPase activity of Hsp70s [39,40]. Hsp40s are classified in three
classes depending on their domain organization and composition (Figure 1A): i) Class A (or Type I)
contains a J-domain followed by a G/F-rich region, a zinc binding domain (ZBD), and a C-terminal
domain (CTDI and II) that ends in a dimerization motif and has the ability to interact with peptides
rich in aromatic residues [41]; ii) Class B (or Type II) proteins have a similar domain composition and
organization but lack the ZBD; iii) and Class C (or Type III) is a highly diverse group with specific
functions that only shares with the other groups the presence of the J-domain. The diversity of the
Hsp40 family is associated with its ability to drive the function of Hsp70s to a plethora of specific
processes and subcellular localizations [28]. Class A and B Hsp40s are ATP-independent cochaperones
of Hsp70s that assist in the quality control of the proteome. Human DnaJB1, the main cytosolic
heat shock inducible class B Hsp40, displays disaggregase activity in cooperation with Hsc70 [25–27].
Aggregate reactivation by Hsc70 is enhanced when DnaJB1 is combined with DnaJA2, a class A Hsp40,
due to the formation of transient complexes between both J proteins that might tether higher order
Hsc70 supercomplexes [42].
Hsp40s exhibit holdase activity, due to their ability to bind substrates, preventing their aggregation
and most likely modifying their conformation [43–45]. Small peptides bind in a hydrophobic pocket
located in the CTD [41], whereas recognition and stable interaction with client proteins also involve
the zinc binding and the G/F domains [43,46,47]. Hsp40s transfer substrates to Hsp70 by a mechanism
poorly understood, concomitantly stimulating the ATPase activity of the chaperone and trapping of the
substrate [48]. The structure and the sequence of the J-domain are highly conserved in the Hsp40 family.
This domain is formed by four α-helices (I-IV) folded around a well-defined hydrophobic core [49,50].
The recently published structure of the complex between Escherichia coli DnaK and the J-domain of DnaJ
reveals the details of the interaction (Figure 1C) [31]: (1) the common HPD motif contacts residues at
the linker, NBD and SBD of DnaK; (2) helix II establishes interactions with the linker and NBD; (3) and
helix III interacts with the SBD. Using this tripartite interaction interface, the J-domain can sense the
occupancy of the substrate binding site and concomitantly stimulate ATP hydrolysis. It is important
to mention that all the essential residues engaged in these contacts between the E. coli proteins are
conserved from bacteria to humans [51]. Other regions involved in the interaction of Hsp40 with
Hsp70 chaperones are the CTD of Hsp40s and the SBD and conserved C-terminal EEVD motif of
cytosolic Hsp70s [52–55]. The EEVD motif of Hsp70 is also involved in the interaction of Hsp70 with
specific cofactors, such as HOP, which uses its three tetratricopeptide repeat (TPR) domains to bind
the C-terminal EEVD motifs of Hsp70 and Hsp90, thus facilitating substrate handover between these
foldases [56]. On the degradation pathway, CHIP also associates with this motif of Hsp70 through its
TPR domain, binding at the same time the enzymes necessary to ubiquitylate the substrates that will
be target for degradation [57,58].
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Hsp110 chaperones are the remaining components in metazoan cells required for, among other
functions, an efficient protein aggregate reactivation in vitro and in vivo [25,26,59]. The human
genome contains three isoforms belonging to this family: Hsp105 (HSPH1), Apg2 (HSPH2), and Apg1
(HSPH3), all of which support in vitro reactivation of protein aggregates by HspA8 and DnaJB1 [26].
Hsp110 proteins are closely related to Hsp70s and share a similar domain organization, e.g., they contain
the aforementioned NBD and SBD [60] connected by an amphipathic linker instead of the conserved
hydrophobic linker of Hsp70s (Figure 1A). Hsp110s are larger proteins due to the insertion of a proline-rich
acidic subdomain (AS) in the β-sandwich of the SBD, and an extension of the intrinsically disordered
C-terminal segment [21]. The AS is involved in the interaction with Hsp70 and in the regulation of
its ATPase/conformational cycle [61], and both the AS and the C-terminal domain participate in the
correct intracellular localization of the isoforms α and β of Hsp105 [62,63]. Although Hsp110s exhibit
ATPase activity, they lack the Hsp70-like allosteric docking/undocking of NBD and SBD coupled to ATP
binding and hydrolysis, displaying limited conformational changes [64–66]. Proteins of the Hsp110
family act as holdases, binding and protecting unstable substrate proteins from aggregation [67,68],
and regulate the ATPase and conformational cycle of Hsp70s functioning as nucleotide exchange
factors [69,70]. They promote fast nucleotide exchange rates, clamping lobe IIb of Hsp70 NBD and
inducing a sideways rotation that opens the nucleotide binding cleft and reduces the chaperone affinity
for ADP. Hsp110 and Hsp70 form stable complexes stabilized by an extensive interaction interface
formed by the NBDs of both proteins and the C-terminal SBDα of Hsp110 (Figure 1D) [33,71].
4. Interaction of Chaperones with Substrate Proteins and Protein Aggregates
Molecular chaperones play a pivotal role in maintaining protein homeostasis in the cell by
modulating protein conformational states and regulating the transition from the native protein
conformation to the aggregated or amyloid states [72–74]. Among them, Hsp70s have an essential
role in protein folding, disaggregation, and degradation. The recently proposed model for Hsp70
functioning as a “multiple socket” postulates that Hsp70 provides a physical platform for the binding of
client proteins, other chaperones, and cochaperones. The final destiny of the client protein is regulated
by the combination of Hsp70 interactions that occur in different cellular contexts. In collaboration
with Hsp90 and several cofactors, as Hsp40s and Hop, coordinates the folding and maturation of key
regulatory client proteins. In complex with CHIP and specific NEFs, directs the substrate to proteasomal
degradation, whereas the interaction with specific Hsp40s and Hsp110-type NEFs engages the chaperone
in the reactivation of protein aggregates [75]. It is worth mentioning that the interaction of chaperones
with native protein conformations regulates important biological activities, and that this interplay
is sensitive to their phosphorylation status (see below). A detailed list of the chaperone substrates
related to neurodegenerative pathologies can be found in [76]. Chaperones follow different strategies
to fight protein misfolding and aggregation. First, they transiently interact with aggregation-prone
regions of misfolded monomeric proteins or intrinsically disordered proteins, inhibiting their initial
oligomerization into seeding competent aggregates and facilitating the folding into their native state
once the proteotoxic stress ceases. This initial step is essential for aggregation to occur, and therefore its
inhibition could solve aggregation-associated diseases. Canonical Hsp40s, sHSPs, Hsp70, and Hsp110
follow this strategy, whereas noncanonical Hsp40s prevent primary nucleation by stabilizing oligomeric
states before they convert into aggregation seeds (review in [76]). Chaperones can also neutralize
the toxic protein oligomers by forming higher-order, mixed complexes that hamper their unspecific
interaction with other cellular proteins, thus reducing their toxicity [77,78]. They can also reverse
protein aggregation, either passively, binding monomers that dissociate from aggregates or fibrils,
or actively, accelerating depolymerization and fragmentation of fibrils. Amyloid fibrils of αsyn [27,79]
and Htt Exon1 [80] can be disaggregated by the cooperative action of human HSPA8 (Hsc70), DNAJB1,
and NEFs of the Hsp110 family.
Solubilization of polypeptide chains depends upon the interaction of the chaperones with
the aggregate, which is most likely the rate limiting step of the reactivation reaction, as protein
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aggregate solubilization correlates with refolding of the extracted unfolded molecules [61,81,82].
Similar to the bacterial system, the initial binding of DnaJB1 to the aggregate surface efficiently recruits
Hsc70 [61,83]. Apg2 further increases binding of Hsc70 in agreement with the refolding stimulation
provided by Hsp110 [25,26,61]. In contrast to Hsc70, Apg2 interacts poorly with protein aggregates,
being more effective in recruiting Hsc70 and promoting aggregate reactivation at substoichiometric
concentrations [26,61]. These findings indicate that Apg2 possibly plays a catalytic role in the
solubilization of protein aggregates compatible with its nucleotide exchange role, and suggest that the
human (metazoan) disaggregase core is built by Hsc70 and Hsp40 proteins. Different models have been
proposed to illustrate how Hsp70 chaperones exert force on polypeptides: the traditional power stroke
and molecular ratchet, and the currently most accepted, entropic pulling model (Figure 1E) [84,85].
This model considers the thermodynamic behavior of molecules in constrained spaces. Hsp70 molecules
bound to aggregated polypeptide chains experience a considerable reduction of their degrees of freedom
and, therefore, of their entropy, since they are apposed against the aggregate surface. Binding of Hsp70
might induce localized partial unfolding of the polypeptide favoring movement of the chaperone
away from the surface, along with the bound substrate. This would result in an immediate increase
in entropy, which could be translated into a favorable free energy change that can be converted into
directional force to unravel polypeptides from the aggregate.
5. Regulation of Chaperone Activity by Phosphorylation
Recent studies indicate that molecular chaperones undergo PTMs, and that their phosphorylation
regulates important cellular processes, such as cell cycle progression, apoptosis, protein degradation,
resistance to anticancer therapeutics, and host–pathogen interaction. We focus in this section on the
effect that phosphorylation of specific residues of members of the Hsp40, Hsp70, and Hsp110 chaperone
families has on their biological function (summarized in Table 1).
Table 1. Phosphorylation sites identified in members of the Hsp70, Hsp40, and Hsp110 chaperone
families with known effects on their structure and function. hs: Homo sapiens; sc: Saccharomyces cerevisiae;
ec: Escherichia coli; mm: Mus musculus.
Chaperone Phosphorylation Site(s) Structural/Functional Consequence(s) Reference
hsDnaJB1 Ser149, Ser151 and Ser171 Inhibition of HSF1-mediated transcription [86]
hsCSP
(DnaJC5) Ser10
Order-to-disorder transition. Modulation of neurotransmitter release by
inhibiting binding to syntaxin and synaptotagmin [87]
hsCSP
(DnaJC5) Ser10 and Ser34
Protection of the presynaptic terminal by promoting HSP70 chaperone
activity [88]
hsHsp105α
(HSPH1) Ser509 Inhibition of the Hsp105-induced suppression of Hsc70-mediated refolding [89]
hsHsp70
(HSPA1A) Ser631 Regulation of SOD2 import into the mitochondria and redox balance [90]
hsHsp70
(HSPA1A) Tyr524 Enhanced nuclear accumulation and heat-shock injury resistance [91]
hsHsc70
(HSPA8) Thr495 Inhibition of Hsp70 ATPase and refolding activities [92]
ecHsp70
(DnaK) Thr504
Stabilization of Hsp70 antiparallel dimers to position the client for transfer
to Hsp90 [93]
hsHsc70
(HSPA8) Thr636 Enhanced interaction with HOP [94]
hsHsc70
(HSPA8) Ser631 and Ser633
Recruitment of Hsc70 to the centrosomes leading to mitotic spindle
elongation and prevention of apoptosis [95]
scHsp70
(Ssa1) Thr36 Regulation of the cell cycle progression [96]
mmHsc70
(Hspa8) Tyr288 Cell uptake of methotrexate [97]
hsHsp70
(HSPA1A) Ser486 Inhibition of apoptosis [98]
hsHsp70
(HSPA1A) Thr66 Promotion of K-fiber assembly and mitotic progression [99]
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5.1. Hsp40
Heat shock protein 40 (Hsp40) acts as a cochaperone of the Hsp70 family, to promote protein
folding, transport, and degradation [100]. The human Hsp40 family contains more than 41 members,
some of which can exist as phosphoproteins in the cell (Figure 2; see PhosphoSitePlus -http://www.
Phosphosite.org-) [101]. However, information on the protein kinases and phosphatases responsible
for their (de)phosphorylation and the functional relevance of this post-translational modification is
scarce. A few examples have succeeded in the identification of the kinases involved in phosphorylation
of specific Hsp40 residues.
One of these studies has shown that Hsp40/DnaJB1 is a substrate for mitogen-activated protein
kinase 5 (MK5) [86]. MK5 and DnaJB1 form complexes in cells, which are stabilized through interactions
between the C-terminal regions of both proteins. This interaction abrogates phosphorylation of DnaJB1
at several residues in vitro, whereas in vivo the chaperone is phosphorylated at Ser-149 or/and
Ser-151 and Ser-171. These residues are conserved in DnaJB1 from other species, underscoring the
importance of these putative phosphorylation sites. Substitution of these three amino acids by
Ala did not completely abolish phosphorylation of the proximal C1 fragment, which encompasses
residues 106–175, suggesting that other residues, such as Ser-132, Thr-142, and Thr-165, which are
putative phosphorylation sites within this fragment, may also function as MK5 phosphoacceptor
sites. Additional phosphorylation sites might also be located at other regions of DnaJB1 (see below),
for instance Ser-16 at the J-domain, which is also highly conserved in DnaJB1 from other species,
could also be phosphorylated in vitro. Furthermore, the finding that substitution of this residue
by non-phosphorylatable Ala did not cancel in vitro phosphorylation of the J-domain by MK5,
also suggests that other residues (Thr-8 and Ser-56), might be potential target sites for this kinase.
MK5-dependent phosphorylation of the Hsp70/DnaJB1 mixture stimulates the ATPase activity,
suggesting that phosphorylated DnaJB1 may enhance the functional cycle of Hsp70. Although the
precise mechanism of action still awaits to be unraveled, phosphorylation of DnaJB1 by MK5 also
stimulates repression of the transcriptional activity of HSF1. It seems that the cochaperone does not
hamper its binding to DNA, but rather interacts with the trans-activation domain of HSF1, changing its
conformation [102].
Another example of a member of the Hsp40 protein family that undergoes phosphorylation is the
cysteine string protein (CSP), which localizes to neuronal synaptic vesicles. CSP belongs to the class C
(DnaJC5) Hsp40 and is highly expressed in all neurons, where it performs a universal neuroprotective
function [103], especially at the presynaptic terminal. Loss of function of this protein is related to
neurodegeneration in humans and model organisms due to misfolding of client proteins involved
in neurotransmission. It binds misfolded proteins, preventing their aggregation, and stimulates
the ATPase activity of the 70 kDa heat shock cognate proteins (Hsc70/Hsp70) to regulate protein
folding [104]. CSP contains unique domains different from the evolutionarily conserved, characteristic
J-domain. The cysteine string domain comprises 13–15 cysteine residues in an approximately 25
amino acid motif, most of which are palmitoylated [105]. This domain is essential for targeting CSP to
synaptic vesicles and for neurotransmitter release in vivo. The C-terminal domain displays relatively
low sequence conservation among CSP homologs from various species, and its function is poorly
understood. Finally, CSPs contain a short N-terminal polypeptide sequence that is phosphorylated
in vivo from worms to humans [106–108]. Phosphorylation of mammalian CSP on Ser10 inhibits
binding to syntaxin and synaptotagmin, but not to Hsc70 [109], and modulates cellular exocytosis release
kinetics [110] (Figure 3A). A recent NMR study has shed light on the Ser-10 phosphorylation-dependent
conformational change that explains the regulation of CSP activity by this PTM. The solution structure
of the serine10-phosphorylated, N-terminal region of CSP (pCSP1-100) reveals an order-to-disorder
transition, which results in a more compact overall structure of pCSP1-100, and in a significant
modification of its surface charge distribution [87]. The conformational phospho-switch reported in
this study provides a structural basis for the previously established effects of Ser10 phosphorylation on
CSP function. This structural change destabilizes and reduces the accessibility of the N-terminal α1
Int. J. Mol. Sci. 2019, 20, 4122 8 of 25
helix, which might explain weakening of specific protein–protein interactions involving this region,
such as complex formation of CSP with syntaxin and synaptotagmin. Interestingly, the overall structure
of the J-domain and the accessibility of the HPD motif required for Hsp70 activation are unaffected by
Ser10 phosphorylation, as expected from the absence of effect of CSP phosphorylation on its interaction
with Hsp70 [107] (Figure 3A).
Figure 2. Mapping of phosphosites in representatives of the human Hsp40, Hsp70, and Hsp110
families. Phosphothreonines (green), phosphoserines (blue) and phosphotyrosines (red) listed in
PhosphositePlus are shown for DnaJB1, Hsc70 (HspA8), and Apg2 (HspA4 or HspH2). Orange dots
represent conserved residues in canonical, cytosolic members of the different chaperone families,
which were found phosphorylated in at least two members of the corresponding families.
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Figure 3. Phosphorylation of members of the Hsp40 and Hsp70 chaperone families regulates important
physiological processes. (A) Phosphorylation of specific residues of CSP (DnaJC5) controls its interaction
with different partners. Posphorylation at Ser10 induces an order-to-disorder transition in the
N-terminal domain of CPS that weakens its interaction with syntaxin and synaptotagmin, but does
not alter its bindig to Hsp70 [87]. However, double phosphorylation at Ser10 and Ser43 favors its
interaction with Hsp70, resulting in a better chaperone activity that supports neuronal cell survival [88].
(B) Reversible phosphorylation of Hsp70 at Ser631 plays a key role in the regulation of mitochondrial
redox balance. Hsp70 assists SOD2 in its efficient translocation to the mitochondria and also drives
SOD2 to degradation in complex with CHIP. Phosphorylation on Ser631 inhibits Hsp70-CHIP complex
formation, thus promoting translocation of SOD2 into the mitochondria. The antioxidant activity
of SOD2 increases the concentration of H2O2 within the mitochondria, inducing expression of a
phosphatase that deactivates Akt1, the kinase that phosphorylates Hsp70. This results in a lower Hsp70
phosphorylation rate, favoring CHIP binding to Hsp70 and SOD2 degradation [90]. (C) Yeast Hsp70
(Ssa1) modulates the cell cycle via its phosphorylation on Thr34, which occurs under nutrient limiting
conditions or during the G2/M phase. Phosphorylation of Ssa1 on Thr34 softens its interaction with
Ydj1 and promotes chaperone binding to phosphorylated Cln3, which leads to Cln3 degradation and to
the next G1 phase [96].
It is important to note that the Lys58 residue that interacts with phospho-Ser10 in CSP is one
of the most highly conserved residues in DnaJ proteins [104], and can be ubiquitinated [111] as the
orthologous Lys residues in human DnaJA1 and DnaJB1. The tight interaction of phospho-Ser10
with Lys58 could regulate the accessibility of E3 ligases, thereby antagonizing CSP ubiquitination.
This finding put forward an attractive mechanism that may regulate protein conformation through
the antagonistic effect of posttranslational modifications. If we consider that 36 of the 41 DnaJ
proteins encoded by the human genome are phosphorylated in serine/threonine residues [112],
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the phosphorylation-induced conformational transition reported for CSP could also apply for the
regulation of other DnaJ/Hsp40 chaperones.
Although it seems clear that phosphorylation of CSP at Ser10 does not modify its interaction with
Hsc70 [112], a recent work by Shirafuji et al. has demonstrated that double phosphorylation of CSP at
Ser10 and Ser34 by protein kinase C (PKC) promotes the interaction between CSP and Hsp70/Hsc70 [88]
(Figure 3A). This interaction further enhances their chaperone activity for SNAP25 and eventually
supports neuronal cell survival. Therefore, PKC-phosphorylation of human CSP at Ser34 in the helix
II of the J-domain is assumed to facilitate complex formation with Hsp70/Hsc70. An alternative
explanation is that phosphorylation of both sites triggers the conformational change that further
stabilizes the Hsp40-Hsp70 complex. Nevertheless, these findings indicate that phosphorylation of
different residues along the polypeptide chain regulates the interaction of CSP with specific partners,
depending on whether the phosphorylated regions are involved in complex formation or induce
conformational changes that favor the interaction with one of them.
5.2. Hsp110
Multiple phosphorylation sites have also been detected in the three isoforms of human Hsp110
(Figure 2 lists phosphosites found in Apg2; see PhosphoSitePlus -http://www.Phosphosite.org-) [101].
Unfortunately, the effect of only one of these phosphorylation sites on the functional properties of
Hsp105α has been characterized [89]. A combination of peptide mapping analysis and the use of
several mutants of this protein reveals that Ser509 is phosphorylated by CK2. This residue was
also found phosphorylated in mammalian COS-7 cells, although other sites were modified as well.
This PTM regulates the association of Hsp110 with Hsc70, affecting mainly to its dissociation from
Hsc70 and therefore to the ability of the Hsp70 system to reactivate luciferase aggregates.
5.3. Hsp70
Hsp70 is a highly conserved chaperone implicated, as aforementioned, in three main general and
essential processes: Protein folding and protein aggregate reactivation, regulation of protein–protein
interactions, and degradation of misfolded proteins [24]. The main regulation factors of the Hsp70
activity in cells are HSF1 and the accessory proteins or cochaperones. Recently, phosphorylation has
appeared as an additional layer of complexity in the regulation of Hsp70 function [113]. An attractive
hypothesis, recently put forward, postulates that specific phosphorylation patterns, similar to those
described for the histone-code, may fine-tune Hsp70 activity [114].
The combined use of global and targeted phosphoproteomics has uncovered 54 phosphorylation
sites on Hsc70 (Figure 2) (see PhosphoSitePlus -http://www.Phosphosite.org-). These essential studies,
however, do not infer the role of these modifications or their combination in the regulation of chaperone
function. When this large number of potential phosphorylation sites are analyzed considering only
those that are predicted to be involved in protein–protein interaction or enzyme activity, the list is
reduced to 313 phosphosites on Hsp70 isoforms across 11 species [115]. We analyze below the specific
functions of Hsp70 that have been associated with phosphorylation of concrete residues.
5.3.1. Regulation of the Mitochondrial Redox Balance
It has been reported that the C terminus of Hsp70 contains phosphorylation sites for kinases
such as Casein kinases [94]. Phosphorylation of this chaperone region regulates import of superoxide
dismutase-2 (SOD2) into the mitochondria and the redox balance (Figure 3B). SOD2 is a member
of the SOD family of antioxidants, and protects cells against mitochondrial oxidative damage [116].
It contains a mitochondrial targeting sequence that drives it across the outer and inner mitochondrial
membranes into the mitochondrial matrix, where it binds manganese (Mn2+) [117]. A peptidase
cleaves the mitochondrial targeting sequence, yielding a fully active protein [118]. Although the
mitochondrial targeting sequence harbors the information essential for SOD2 to navigate the cytoplasm
and to translocate into mitochondria, SOD2 requires assistance from Hsp70 to commit the enzyme to
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mitochondrial translocation pathways [119]. Hsp70 recognizes and binds short hydrophobic sequences
on the amino terminus of SOD2, prevents its aggregation and presents it to the translocation machinery
in an import-competent conformation [120]. In addition to the folding events, Hsp70 also directs SOD2
to the ubiquitin-proteasome system (UPS) for degradation [121], and therefore regulates the abundance
of this protein.
A recent study has demonstrated that phosphorylation/dephosphorylation cycles of Hsp70
control mitochondrial redox balance by modulating CHIP-mediated degradation of SOD2 [90].
Phosphorylation of Hsp70 on Ser631 by Akt1 decreases its affinity for CHIP, and thus promote the
import of SOD2. Phosphorylation induces a structural change in the Hsp70 conformation that enhances
its ability to refold and transport SOD2 to the mitochondria. An increase in the concentration of
mitochondrial H2O2, a product of the SOD2 antioxidant activity, inhibits further import of SOD2 by
inducing the expression of PP2C, a protein phosphatase that deactivates Akt1 kinase and decreases the
rate of Hsp70 phosphorylation. These observations have led to a model of SOD2 signaling whereby,
following cell stimulation, Hsp70 is phosphorylated and increases SOD2 import. The transient nature
of this response is achieved by rapid dephosphorylation of Hsp70, which inhibits SOD2 import and
activity. This study strongly suggests that reversible phosphorylation of Hsp70 could be a physiological
mechanism for the regulation of processes as important as the mitochondrial redox balance.
5.3.2. Host-Pathogen Interaction
Hsp70 phosphorylation has also been involved in the regulation of host–pathogen interactions.
A recent study has shown that Legionella pneumophilia (L.p.) targets Hsp70 to reduce host translation [92].
L.p is a model organism for studying host–pathogen interactions, as many key regulatory pathways,
including host translation and eukaryotic vesicle transport, can be easily manipulated. To control
these host processes, L.p. uses a type IV secretion system to translocate approximately 300 bacterial
effector proteins directly into infected host cells [122]. One of this factor, a eukaryotic-like, Ser/Thr
effector kinase known as LegK4 [123], phosphorylates Hsp70 at Thr495 in the substrate-binding
domain, disrupting its ATPase activity and greatly inhibiting its protein folding capacity. This results
in translation inhibition and in an increase in the amount of Hsp70 bound to highly translating
polysomes. Phosphorylated Hsp70 might be unable to fold nascent polypeptides correctly and
thus, remains associated with the polysomes longer than usual. The ability of LegK4 to inhibit host
translation via a single phosphorylation uncovers a role for Hsp70 in protein synthesis and directly
links it to the cellular translational machinery. This study also describes a pathogen using a kinase to
phosphorylate host Hsp70 during infection.
5.3.3. Regulation of Hsp70 Dimerization by Phosphorylation
Hsp40 mediates complex formation between Hsp70 and client proteins prior to interaction with
Hsp90 [24]. The Hsp70/90 system requires a plethora of accessory proteins to provide specificity
and regulate its interactions with client proteins [124]. Hsp70 binds extended hydrophobic peptide
sequences and acts at an early stage to recognize partially folded client proteins, unlike Hsp90 that
is believed to interact with substrates in a near-native conformation. In contrast to Hsp90, Hsp70 is
primarily monomeric in solution [125], although dimerization has also been reported for DnaK [126].
Specific mutations of DnaK designed to disrupt the crystallographic dimer interface and to probe
its functional significance [127], displayed a defective chaperone activity and Hsp40 interactions.
The Hsp70/Hsp40 chaperone system is also required to regulate client binding to Hsp90 and to load
Hsp90 with a client protein [128]. The cochaperone Hop bridges the Hsp70 and Hsp90 chaperone
systems [129], and inhibits the ATPase activity of Hsp90, stabilizing the client-loading conformation
and facilitating client proteins handover [130].
In common with many chaperone systems, Hsp70/90-substrate interactions have proven challenging
to study with traditional biophysical techniques due to their dynamic nature and compositional
heterogeneity. This explains the requirement of alternative experimental methods to characterize them.
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A recent study combining crosslinking-mass spectrometry and structure modeling has demonstrated
that phosphorylation of Thr504 on mammalian Hsp70 is critical for Hsp70 dimerization and promotes
a client-loading complex comprising Hsp90, Hsp70, and Hsp40. Based on these results, the authors
proposed a model in which Hsp70 antiparallel dimerization, stabilized by PTMs, positions the client
for transfer from Hsp70 to Hsp90 [93]. The Hsp70 dimer interface is stabilized by electrostatic
interactions, which are further strengthened by phosphorylation of Thr504. This phosphosite
is located close to the hinge region between the two subdomains of the SBD, in a lysine-rich
pocket that orients it towards the subunit interface for interactions with several lysine residues,
which could stabilize the ADP conformation in the antiparallel dimer. A question that, however,
remains unanswered is whether this Hsp70 antiparallel arrangement occurs during the functional cycle
of the chaperones. In several pathologies, including cancer, the higher chaperone concentration and
enhanced phosphorylation [131,132] could stimulate formation of antiparallel Hsp70 dimers, which in
turn might facilitate substrate protein transfer from Hsp70 to Hsp90. Further work is necessary to find
out if this phosphorylation is constitutive or is sensitive to the conditions that client proteins sense in
the cellular context.
5.3.4. Regulation of the Balance between Protein Folding and Degradation
Hsp70 usually interacts with client proteins several times before they fold properly. When these
interaction cycles are not productive, it will target the client through different degradation pathways.
A recently proposed model for Hsp70 functioning, puts forward that the chaperone provides a physical
platform where client proteins, other chaperones and co-chaperones can bind. The fate of the client
protein is governed by the set of protein interactions that are promoted under different cellular
contexts [75]. During protein folding in eukarya, Hsp70 and Hsp90 chaperones work in a coordinate
manner, Hsp90 acting downstream Hsp70. They are assisted by several cochaperones like Hsp40s,
which have an essential role in targeting substrates to Hsp70, or Hsp70/Hsp90-organizing protein
(HOP) that facilitates substrate transfer from Hsp70 to Hsp90 [130]. Protein degradation, in contrast,
requires tagging of the protein with one or more ubiquitin molecules by the ubiquitin-proteasome
system (UPS) to entry into the proteasome for degradation [133]. This connection between Hsp70 and
the UPS is controlled by the interaction of one component of the UPS, the ubiquitin ligase CHIP with
the Hsp70 C-terminus, which facilitates the ubiquitination of Hsp70-bound client proteins.
In proliferating cancer cells, phosphorylation of the C-terminus of Hsp70 (Thr636) and Hsp90
enhance their interaction with the co-chaperone HOP, increasing client protein stability and thus driving
cancer growth. In contrast, nonphosphorylated chaperones preferentially bind CHIP, resulting in
degradation of client proteins. Therefore, phosphorylation of the C-terminal substrate-binding domains
of these chaperones regulates the client triaging process, by selecting the combination of proteins that
interact with Hsp70 [94]. Interestingly, Thr636 phosphorylation has a small effect on the binding of
other co-chaperones that share interacting surfaces on Hsp70 with CHIP and HOP [134]. Although the
mechanism by which Hsp70 phosphorylation regulates the selectivity of cochaperone binding is far
from being understood, it is clearly an interesting facet of the chaperone quality control.
5.3.5. Regulation of the Cell Cycle Progression
Hsp70 phosphorylation has also been involved in the regulation of the cell cycle. The yeast Hsp70,
Ssa1 is phosphorylated in Thr36 by different kinases, resulting in an important switch in Hsp70-client
interactions that has been characterized by proteomic analysis of the Ssa1 interactome [96] (Figure 3C).
In the G2/M phase, Clb cyclins activate Cdk1, which phosphorylates Ssa1, triggering displacement
of the member of the Hsp40 family, Ydj1, and binding of the G1 cyclin Cln3 that is primed for
degradation. Phosphorylation of Hsp70 Thr36 can also be achieved during nutrient limiting conditions
by the stress CDK Pho85 activated by Pcl cyclins, which also drives exchange of Ydj1 by Cln3,
which may be phosphorylated by Pho85 on the PEST domains. Both processes promote Cln3
degradation, preventing accumulation of Cln3 and resetting the cell for the next G1. The finding that
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CDK-dependent Thr38 phosphorylation on mammalian Hsc70 similarly regulates Cyclin D1 binding
and activity, strongly suggests that Hsp70 chaperones can be dynamically activated to transduce cell
signaling into cell cycle control.
5.3.6. Hsp70 Phosphorylation Regulates Drug Resistance in Cancer Cells
Folates are key one-carbon donors in the process of DNA and RNA syntheses [135].
Methotrexate (MTX), a folate analog, is an antifolate chemotherapeutic agent that inhibits folate
metabolism by inhibiting DHFR. Folates and folate analogs use different transport systems to enter
cells. The reduced folate carrier (RFC), which displays high affinity for reduced folate and MTX, is the
major route for the uptake of antifolate chemotherapeutic drugs in mammalian cells and tissues [136].
Aberrant functions of MTX transports can be the obstacle to successful transportation of MTX into
cancer cells and may further lead to MTX resistance in cancer therapy. In this context, it has been
shown that the NBD of Hsc70 binds MTX in different cancer cells [97]. Based on this experimental
evidence, it was proposed that Hsc70 might mediate transport of MTX into the cell, cooperating
with other MTX-interacting proteins. The finding that Hsc70 is phosphorylated on Tyr288 in MTX
sensitive but not in resistant cells raised the proposal that Hsc70 phosphorylation can mediate entry of
MTX into the cell and therefore modulate cancer growth and cellular resistance. As aforementioned,
the identity of the kinases and phosphatases responsible for Tyr288 (de)phosphorylation remains
unknown, and consequently, the possibility to modify its phosphorylation status for clinical purposes
requires further studies.
5.3.7. Regulation of Apoptosis
Hsp70 enhances cell growth, suppresses senescence, confers resistance to stress-induced apoptosis
and serves as a good tumor marker [137,138]. A recent work has established that phosphorylation
of Hsp70 at Ser486 was important for anti-apoptosis induced by serum starvation [98]. This PTM
is mediated by the Retinoic Acid-Induced 16 (RAI16) protein, which after activation functions as a
protein kinase A anchoring protein that also binds Hsp70. Thus, by holding in close proximity both
PKA and Hsp70, RAI16 promotes Hsp70 phosphorylation, preventing cleavage of caspase-3 and
apoptosis. Elevation of the cellular concentration of cAMP activates the PKA holoenzyme anchored to
RAI16, which phosphorylates RAI16 on Ser325. This induces the recruitment of 14-3-3θ, which inhibits
RAI16-mediated, PKA phosphorylation of Hsp70 and promotes apoptosis.
Together, these studies show that multiple kinases phosphorylate Hsp70 for selective signaling
purposes, and reveal a complex phosphorylation-induced regulation of Hsp70 chaperone activity,
which is essential to modulate diverse signaling pathways.
6. Phosphorylation as Part of the Chaperone Code
With the improvement of the experimental tools to identify PTMs, it has become clear that
chaperones undergo extensive PTMs (Figure 2). However, the enzymes responsible for these
modifications and the functional consequences that PTMs might have on these proteins remain
largely unknown. Considering the overwhelming number of PTMs experimentally observed in
chaperones, it has been proposed that a code, similar to that proposed for histones, does exist for
chaperones [113]. Decrypting how this chaperone code regulates chaperone activity requires the
detailed characterization of the effect that PTMs have on (i) the ATPase activity of Hsp70 and Hsp110;
(ii) the conformation of the three components of this system; and (iii) the interaction of Hsp70 with its
cochaperones and with a plethora of substrate proteins. It is of particular importance to note that, as far
as phosphorylation is concerned, all chaperones and most likely some of their client proteins [139]
can be phosphorylated at multiple sites, and therefore that the variable phosphorylation state of each
of these components might be important to regulate their interaction and final functional outcome.
Addressing the following questions is necessary to understand how the chaperone code might function.
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6.1. How Phosphorylation Regulates the Conformation and Activity of These Chaperones?
Although most human proteins contain only few phosphorylation sites, some, as the chaperones
studied in this work, do have multiple phosphorylation sites [140]. The ability of a dianionic phosphate
group to establish extensive hydrogen bond networks and salt bridges with neighboring residues
explains how phosphorylation affects stability, kinetics and dynamics [141]. Predicting the impact
of phosphorylation on chaperone conformation and activity is not straightforward, mainly due to
two reasons. First, the presence of multiple phosphorylation sites in the three chaperone families
(Figure 2). Multisite phosphorylation complicates the accurate quantitative characterization of the
phosphorylation status of the chaperones in the cell under different conditions, because multiple
combinations of phosphorylated peptides can coexist, making their detection especially difficult.
Without this identification, it is hard to assign a specific conformation to the distinct phosphorylation
states that chaperones may have. Although mass spectrometry can sometimes provide insight into
dynamics of post-translational modifications, a quantitative determination is not always possible [142].
Second, the flexible character of chaperone structure in solution poses an extra difficulty in assessing
the effect of phosphorylation, and other PTMs, on the conformational cycle of chaperones [143].
Analyses of phosphorylation in different proteins revealed the diversity and heterogeneity of its
effects on protein structure [144], as it can impact protein structure at local as well as global levels.
Although recent crystallographic descriptions of the ATP-bound states gave the impression that
different Hsp70s adopt the same domain-docked and domain-undocked states, growing experimental
evidence suggests that in solution each chaperone has a complex conformational landscape and coexists
as a heterogeneous ensemble of several conformations [145,146]. The population of each conformation,
which in turn controls its ATPase and client interaction, seems to be under precise regulation by
allosteric hotspots, regions that modulate chaperone conformational transitions. Subtle perturbations,
such as amino acid substitutions, ligand binding or PTMs, at these allosteric hotspots have been
shown to modify the chaperone conformational cycle, adjusting its chaperone activity [147]. As not all
allosteric hotspots are fully conserved, functional diversity and real-time Hsp70 activity within the
Hsp70 family might be regulated post-translationally, e.g., through covalent modifications, such as
phosphorylation, and/or interactions with co-chaperones [51,148]. These studies also suggest that
different members of the Hsp70 family apparently fine-tune their function post-translationally through
adjustments of their conformational landscape rather than by altering chaperone structure [143].
Information on how phosphorylation could modulate the conformation of these chaperones is at
present scarce.
Multiple phosphorylation can occur through different mechanisms. It can be sequential or random.
In sequential phosphorylation, sites are modified in a strict order of events where phosphorylation of one
site depends on the phosphorylation state of another. Sequential phosphorylation has been observed for
several kinases, especially Ser/Thr kinases [149]. In contrast, random phosphorylation does not require
a strict order of phosphorylation events. The identification of most kinases that phosphorylate these
chaperones awaits further studies as does the mechanism they follow to phosphorylate multiple residues.
Multisite phosphorylation can expand the regulation patterns, giving a more precise modulation of the
phosphorylation-induced protein conformational change [150], and cooperatively regulating binding
affinity to nucleotide, substrate proteins and co-chaperones [151,152]. Interestingly, large scale analyses
revealed that multiple phosphorylation sites are not distributed randomly, often being clustered on
a particular protein region [153,154]. Retinoblastoma protein (Rb) is an example of a protein with
multiple phosphorylation sites and concerted phosphorylation patterns with very specific functional
roles. Rb contains 13 different Ser/Thr phosphorylation sites that can be grouped into eight clusters,
which mostly reside in flexible loop regions between structured regions or domains, and mediate
domain-domain, domain-loop, and protein–protein interactions [155,156].
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A similar scenario might occur in chaperones, as many of the experimentally observed, although not
all, phosphorylated residues are close in the protein sequence or might form clusters upon folding,
as seen in some of the available structures and models. As an example, the fully conserved residues
Thr13, Tyr15, Ser16, Thr37, Tyr40, Ser41, and Tyr149 form one of these clusters in the NBD of Hsp70,
surrounding the ATP binding pocket (Figure 4A). One of these residues (Thr13) interacts directly with
the nucleotide and with Lys71, which is essential for ATP hydrolysis [157], and therefore, could modulate
the ATPase activity of the chaperone. Two other amino acids, Tyr149 and Tyr15, might interfere with
the orientation of the ligand either directly (Tyr149), or indirectly (Tyr15) through the interaction
with residues Glu268 and Arg272 that participate in the correct positioning of the substrate [71].
Phosphorylation of loops L1,2 and L3,4 around the peptide binding site at the SBDβ subdomain
of Hsp70 might also be important to regulate chaperone-client interaction (Figure 4B). A recent
Molecular Dynamics (MD) study suggests that both loops establish contacts in the domain-undocked,
substrate-bound conformation, whereas in the domain-docked conformation these interactions are
disrupted [147]. The sensitivity of this conformational transition to the presence of the NBD and
peptides indicates that they are part of the allosteric network that enables control of substrate binding
and release. This suggestion has been experimentally proved by substituting different residues of
these loops and, notably, by exchanging them in DnaK [158]. The mutated proteins showed a lower
affinity for substrates [159], a change in the binding specificity for different substrates and in some
cases the loss of the refolding activity of the chaperone [160,161]. Phosphorylation of Tyr431 in L3,4
and Thr405 and Thr411 in L1,2 might modulate their interaction as it could weaken inter-loop contacts,
favoring the fully open arrangement of the loops (Figure 4B). In this conformation, the dynamics
around the substrate binding loops would be essential for fast and efficient client binding to Hsp70.
Phosphorylation of residues at these loops, as Tyr431, might also modify contacts on the SBDβ-SBDα
interface that are important to regulate the allosteric properties of Hsp70 [162].
6.2. How Phosphorylation Modulates Intermolecular Interactions?
Protein–protein interactions control many cellular processes and main signaling pathways involve
dense networks of interacting proteins and phosphorylation events. Analysis of phosphorylation
sites on protein–protein binding interfaces has shown that protein interfaces of transient homo-
and hetero-oligomers are statistically enriched in phosphorylation sites compared to non-interfacial
protein surface sites [140,163]. There are different ways by which phosphorylation could modulate
the chaperone activities that rely on protein–protein interactions, namely the holdase and foldase
activities. Chaperones, as aforementioned, can inhibit aggregation of unstable protein conformations,
and therefore display holdase activity. Phosphorylation of these proteins occurs in all protein domains,
including those that have been related to client protein binding, namely the CTD, G/F and Zn-binding
domain of Hsp40, and the SBDs of both Hsp70 and Hsp110 (see Figure 2). Furthermore, the fact that
some substrates might also undergo phosphorylation [139,164], broadens the possibility that this PTM
could regulate chaperone-substrate interactions. As an example of a possible effect of phosphorylation
on a region of DnaJB1 involved in complex formation with substrate proteins, we analyze in Figure 4C
the residues that have been found phosphorylated in the CTDI subdomain of DnaJB1 (Ser171, Tyr176,
and Ser177). They form a cluster, together with the conserved Glu173 and Glu174 at the short helix
located in the hinge that connects both CTD subdomains, and therefore their phosphorylation could
modify the relative position of these protein regions. The phosphorylated residues could also interact
with amino acids at the CTDII, such as the conserved Arg311, which is involved in a hydrogen bond
network (Figure 4C). Moreover, we cannot rule out that the accumulation of five negatively charged
residues on a seven amino acid long helix could destabilize it. Substitution of Tyr176 and Ser177 in
members of the DnaJB class might also be related to their ability to bind distinct client proteins, and
therefore to recruit Hsp70 for specific functions (Figure 4C).
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Figure 4. (A) Phosphorylated residues near the nucleotide binding site of Hsc70 (PDB ID: 4H5T).
Orange spheres represent the oxygen of the hydroxyl groups to where the phosphate group would be
attached. (B) The same for the substrate binding site of Hsc70 (PDB ID: 4PO2), showing the charged
residues that could establish ionic interactions with the phosphate group. Alignment of different
Hsp70s from human (hs), yeast (sc) and E. coli (ec). (C) Phosphorylated residues at the interface between
the CTDI and CTDII subdomains of DnaJB1 (PDB ID: 2QLD). Alignment of distinct members of class B
human Hsp40. Conserved acidic residues are shown in red and charged residues that could interact
with the phosphate group are indicated as in (B). Alignments were done with ClustalW2. It is important
to note that it is unknown whether the marked residues can be phosphorylated at the same time.
Altering the affinity of the central Hsp70 chaperone for its cochaperones, i.e., in our case Hsp40
and Hsp110, is another way by which phosphorylation might affect the foldase and disaggregase
activities of the system, as both require their cooperation. This change might be a direct consequence
of introducing a charge group in the interaction surface or an indirect one, through an allosteric
conformational change brought about by phosphorylation of (a) residue(s) not necessarily located
at the protein–protein interface. This could be essential for the functional outcome, as cochaperones
besides modulating the ATP cycle of their respective chaperone, direct it to specific cellular processes
and client proteins. Thus, modifications that change the preference of the chaperones toward different
cochaperones may ultimately have critical consequences on the fate of substrate proteins (folding or
degradation), and on the processes in which the system is involved.
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The large number of phosphorylation, and other PTMs, sites in the three proteins analyzed,
scattered throughout all domains (Figure 2), suggests that synchronization of multiple PTMs through
a combinatory code could time diverse chaperone functions and mediate recognition of multiple
substrates with high specificity, as recently proposed for Hsp90 [165]. Phosphorylation can also modify
other PTMS, a property known as crosstalk, as put forward for CSP (see above). Post-translational
modification crosstalk occurs in those cases where phosphorylation of one or several residues influences
the modification of another site(s). As an example, phosphorylation in some cases can modulate
subsequent ubiquitylation and the crosstalk between phosphorylation and ubiquitylation is reciprocal,
e.g., phosphorylation can be regulated by ubiquitylation and vice versa [166]. Therefore, unravelling the
chaperone code will also require the characterization of the conformational and functional interplay
between different PTMs. We are only starting to have a sense of the importance of PTMs in the
regulation of Hsps and, clearly, there is a lot more to learn. Understanding the molecular mechanisms
underlying this new and complex layer of chaperone regulation is a huge task that will need years
of work.
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Abbreviations
PTM Posttranslational modifications
Hsp Heat shock protein
PQC Protein quality control
NBD Nucleotide binding domain
SBD Substrate binding domain
CTD C-terminal domain
TLA Three letter acronym
ZBD Zinc binding domain
Apg ATP and peptide-binding protein in germ cells
EEVD Glu-Glu-Val-Asp
sHsp Small heat shock protein
αsyn α-synuclein
Htt Huntingtin
AS Proline-rich acidic subdomain
NEF Nucleotide exchange factor
TPR Tetratricopeptide repeat
MK5 Mitogen-activated protein kinase-activated protein kinase 5
HSF1 Heat shock factor 1
CSP Cysteine string protein
SNAP25 Synaptosomal nerve-associated protein 25
PKC Protein kinase C
SOD2 Superoxide dismutase-2
CHIP C-terminus of Hsc70 interacting protein
Akt1 RAC-alpha serine/threonine-protein kinase
UPS Ubiquitin-proteasome system
PP2C Protein phosphatase 2C
HOP Hsp70/Hsp90 organizing protein
CDK Cyclin-dependent protein kinase
G6PDH Glucose 6 phosphate dehydrogenase
Hsc Heat shock cognate
NMR Nuclear magnetic resonance
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